Peptide Safety and Efficacy When it comes to peptide-based treatments, safety and efficacy are paramount
Dosing calculators and tools for Peak Wellness patients Since Peak Wellness provides compounded medications in multi-dose vials, you need to calculate individual doses using a syringe
Higher doses should be administered only with caution and only where clinical and biochemical considerations make it seem likely that higher doses will be benefit
Published clinical guidelines from organizations including the American Society of Metabolic and Bariatric Surgery and the Obesity Medicine Association have identified GLP-1 receptor agonists as appropriate pharmacological interventions in patients with a BMI of 30 or above (classified as obesity), or BMI of 27 or above with at least one weight-related comorbidity such as type 2 diabetes, hypertension, dyslipidemia, or obstructive sleep apnea - the same criteria framework used by the FDA in evaluating GLP-1 medications for their obesity management indications
Cardiovascular Safety Benefits Long-Term Safety Considerations Managing Side Effects Effectively Comparing GLP-1 Medications When to Contact Your Healthcare Provider Making GLP-1 Treatment More Affordable The Bottom Line on GLP-1 Safety References What Does Research Show About GLP-1 Safety
